Back to GetFilings.com



Table of Contents
 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 

 
FORM 10-Q
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended September 29, 2002
 
Commission file number: 0-21154
 

 
CREE, INC.
(Exact name of registrant as specified in its charter)
 
North Carolina
 
56-1572719
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
4600 Silicon Drive
Durham, North Carolina
 
27703
(Address of principal executive offices)
 
(Zip Code
 
(919) 313-5300
(Registrant’s telephone number, including area code)
 

 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. x  Yes    ¨  No
 
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). x  Yes    ¨  No
 
The number of shares outstanding of the registrant’s common stock, par value $0.00125 per share, as of October 18, 2002 was 72,768,140.
 


Table of Contents
CREE, INC.
 
FORM 10-Q
 
For the Quarter Ended September 29, 2002
 
INDEX
 
          
Page No.

PART I.
 
FINANCIAL INFORMATION
      
Item 1.
 
Financial Statements
      
        
3
        
4
        
5
        
6
Item 2.
      
18
Item 3.
      
28
Item 4.
      
28
PART II.
 
OTHER INFORMATION
      
Item 1.
      
29
Item 6.
      
29
    
30
    
31

2


Table of Contents
PART I—FINANCIAL INFORMATION
 
Item 1—Financial Statements
 
CREE, INC.
CONSOLIDATED BALANCE SHEETS
(In thousands, except per share data)
 
    
September 29,
2002

    
June 30,
2002

 
    
(Unaudited)
        
ASSETS
                 
Current assets:
                 
Cash and cash equivalents
  
$
54,253
 
  
$
73,744
 
Short-term investments held to maturity
  
 
44,274
 
  
 
32,396
 
Marketable securities available for sale
  
 
2,609
 
  
 
6,008
 
Accounts receivable, net
  
 
42,692
 
  
 
34,592
 
Interest receivable
  
 
3,968
 
  
 
2,083
 
Inventories, net
  
 
15,923
 
  
 
17,966
 
Deferred income taxes
  
 
1,122
 
  
 
1,122
 
Prepaid expenses and other current assets
  
 
4,088
 
  
 
5,994
 
    


  


Total current assets
  
 
168,929
 
  
 
173,905
 
Property and equipment, net
  
 
220,536
 
  
 
211,685
 
Long-term investments held to maturity
  
 
65,550
 
  
 
64,225
 
Deferred income taxes
  
 
26,877
 
  
 
27,365
 
Patent and license rights, net
  
 
4,526
 
  
 
4,251
 
Other assets
  
 
20,959
 
  
 
22,764
 
    


  


Total assets
  
$
507,377
 
  
$
504,195
 
    


  


LIABILITIES AND SHAREHOLDERS’ EQUITY
                 
Current liabilities:
                 
Accounts payable, trade
  
$
12,628
 
  
$
13,075
 
Accrued salaries and wages
  
 
4,202
 
  
 
4,010
 
Other accrued expenses
  
 
6,803
 
  
 
4,969
 
    


  


Total current liabilities
  
 
23,633
 
  
 
22,054
 
Long term liabilities:
                 
Other long term liabilities
  
 
22
 
  
 
37
 
    


  


Total long term liabilities
  
 
22
 
  
 
37
 
 
Shareholders’ equity:
                 
Preferred stock, par value $0.01; 3,000 shares authorized at September 29, 2002 and June 30, 2002; none issued and outstanding
  
 
—  
 
  
 
—  
 
Common stock, par value $0.00125; 200,000 shares authorized; 72,767 and 72,729 shares issued and outstanding at September 29, 2002 and June 30, 2002, respectively
  
 
91
 
  
 
90
 
Additional paid-in-capital
  
 
508,548
 
  
 
508,432
 
Deferred compensation expense
  
 
(562
)
  
 
(696
)
Accumulated deficit
  
 
(21,840
)
  
 
(25,722
)
Accumulated other comprehensive loss, net of tax
  
 
(2,515
)
  
 
—  
 
    


  


Total shareholders’ equity
  
 
483,722
 
  
 
482,104
 
    


  


Total liabilities and shareholders’ equity
  
$
507,377
 
  
$
504,195
 
    


  


 
The accompanying notes are an integral part of the consolidated financial statements.

3


Table of Contents
CREE, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share data)
(Unaudited)
 
    
Three Months Ended

    
September 29,
2002

  
September 23,
2001

Revenue:
             
Product revenue, net
  
$
42,154
  
$
38,578
Contract revenue, net
  
 
6,657
  
 
4,588
    

  

Total revenue
  
 
48,811
  
 
43,166
Cost of revenue:
             
Product revenue
  
 
25,117
  
 
19,912
Contract revenue
  
 
4,989
  
 
3,350
    

  

Total cost of revenue
  
 
30,106
  
 
23,262
    

  

Gross profit
  
 
18,705
  
 
19,904
Operating expenses:
             
Research and development
  
 
6,564
  
 
4,105
Sales, general and administrative
  
 
7,825
  
 
5,732
Intangible asset amortization
  
 
—  
  
 
2,255
Other expense
  
 
69
  
 
851
    

  

Income from operations
  
 
4,247
  
 
6,961
Interest income, net
  
 
1,400
  
 
2,137
Other expense
  
 
400
  
 
—  
    

  

Income before income taxes
  
 
5,247
  
 
9,098
Income tax expense
  
 
1,364
  
 
2,638
    

  

Net income
  
$
3,883
  
$
6,460
    

  

Earnings per share:
             
Basic
  
$
0.05
  
$
0.09
    

  

Diluted
  
$
0.05
  
$
0.09
    

  

Shares used in per share calculation:
             
Basic
  
 
72,747
  
 
72,952
    

  

Diluted
  
 
74,460
  
 
75,642
    

  

 
The accompanying notes are an integral part of the consolidated financial statements.

4


Table of Contents
 
CREE, INC.
CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)
    
Three Months Ended

 
    
September 29, 2002

    
September 23, 2001

 
Operating activities:
      
Net income
  
$
3,883
 
  
$
6,460
 
Adjustments to reconcile net income to net cash provided by operating activities:
                 
Depreciation of property and equipment
  
 
9,213
 
  
 
7,355
 
Loss on disposal of property, equipment and patents
  
 
69
 
  
 
851
 
Amortization of patent rights
  
 
45
 
  
 
41
 
Amortization of intangible assets
  
 
—  
 
  
 
2,255
 
Amortization of deferred compensation
  
 
134
 
  
 
130
 
Deferred income taxes
  
 
1,371
 
  
 
2,760
 
Tax benefits associated with stock option exercises
  
 
—  
 
  
 
862
 
Changes in operating assets and liabilities:
                 
Accounts and interest receivable
  
 
(9,985
)
  
 
(4,779
)
Inventories
  
 
2,043
 
  
 
(1,720
)
Prepaid expenses and other current assets
  
 
1,906
 
  
 
243
 
Accounts payable, trade
  
 
(447
)
  
 
(3,861
)
Accrued expenses and other long-term liabilities
  
 
2,012
 
  
 
5,599
 
    


  


Net cash provided by operating activities
  
 
10,244
 
  
 
16,196
 
    


  


Investing activities:
                 
Purchase of available for sale securities
  
 
—  
 
  
 
(13,982
)
Purchase of property and equipment
  
 
(16,913
)
  
 
(10,108
)
Purchase of securities held to maturity
  
 
(13,203
)
  
 
(30,000
)
Proceeds from maturities of securities held to maturity
  
 
—  
 
  
 
27,029
 
Increase in other long-term assets
  
 
585
 
  
 
(1,494
)
Capitalized patent costs
  
 
(320
)
  
 
(168
)
    


  


Net cash used in investing activities
  
 
(29,851
)
  
 
(28,723
)
    


  


Financing activities:
                 
Repurchase of common stock
  
 
—  
 
  
 
(9,996
)
Net proceeds from issuance of common stock
  
 
116
 
  
 
541
 
    


  


Net cash provided by (used in) financing activities
  
 
116
 
  
 
(9,455
)
    


  


Net decrease in cash and cash equivalents
  
 
(19,491
)
  
 
(21,982
)
Cash and cash equivalents:
                 
Beginning of period
  
 
73,744
 
  
 
164,562
 
    


  


End of period
  
$
54,253
 
  
$
142,580
 
    


  


Supplemental disclosure of cash flow information:
                 
Cash paid for income taxes
  
 
—  
 
  
$
2,104
 
    


  


 
The accompanying notes are an integral part of the consolidated financial statements.

5


Table of Contents
 
CREE, INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS